These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9918234

  • 1. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis.
    Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, Benali K, Eliaou JF, Kahn MF, Sany J, Meyer O.
    J Rheumatol; 1999 Jan; 26(1):7-13. PubMed ID: 9918234
    [Abstract] [Full Text] [Related]

  • 2. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis.
    Després N, Boire G, Lopez-Longo FJ, Ménard HA.
    J Rheumatol; 1994 Jun; 21(6):1027-33. PubMed ID: 7932409
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [Abstract] [Full Text] [Related]

  • 4. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies.
    Escalona M, López-Longo FJ, González CM, Monteagudo I, Rodríguez-Mahou M, Grau R, Carreño L.
    J Rheumatol; 2002 Oct; 29(10):2053-60. PubMed ID: 12375311
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 6. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
    Abdel-Nasser AM, Mahmoud MH, El Mansoury TM, Osman AM.
    Scand J Rheumatol; 2008 Dec; 37(5):329-36. PubMed ID: 18666028
    [Abstract] [Full Text] [Related]

  • 7. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 8. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 9. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
    Lapin SV, Maslianskiĭ AL, Mazurov VI, Totolian AA.
    Ter Arkh; 2005 Oct; 77(12):53-9. PubMed ID: 16514821
    [Abstract] [Full Text] [Related]

  • 10. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
    Scand J Rheumatol; 2008 Apr; 37(3):183-7. PubMed ID: 18465452
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [Abstract] [Full Text] [Related]

  • 15. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A, Lacaille D, Horne C, Chalmers A, Hoar DI, Balshaw R, Keown PA.
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G.
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [Abstract] [Full Text] [Related]

  • 17. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor.
    Manera C, Franceschini F, Cretti L, Braga S, Cattanec R.
    J Rheumatol; 1994 Nov; 21(11):2021-5. PubMed ID: 7869304
    [Abstract] [Full Text] [Related]

  • 18. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S, Beauvillain C, Renier G, Jeannin P, Masson C, Chevailler A.
    Ann Biol Clin (Paris); 2008 Nov; 66(2):157-64. PubMed ID: 18390426
    [Abstract] [Full Text] [Related]

  • 19. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D, Gülmez D, Hasçelik G.
    Mikrobiyol Bul; 2003 Nov; 37(2-3):163-70. PubMed ID: 14593899
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.